AI Assistant
Blog
Pricing
Log In
Sign Up
HGG-26. DRAMATIC RESPONSE IN A CHILD TREATED FOR GLIOBLASTOMA WITH IMMUNE CHECK POINT INHIBITOR NIVOLUMAB
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
